Pneumonia News

For children hospitalized with community-acquired pneumonia, there is no significant difference between treatment with beta-lactam monotherapy and beta-lactam plus macrolide combination therapy concerning length of stay, intensive care admission, rehospitalization or recovery at follow-up.

Although pneumonia can be prevented by immunization, good hygiene practices and adequate nutrition, it accounted for the deaths of more than 920,000 children aged younger than 5 years worldwide in 2015, according to WHO.

More than 70% of patients hospitalized with community-acquired pneumonia in the United States received antibiotic treatment longer than recommended, according to recent data.

The decrease in 30-day readmissions in Medicare fee-for-service beneficiaries with acute MI, HF and pneumonia was associated with a decrease in 30-day mortality rates after discharge, according to a study published in JAMA.

A multifaceted intervention which included training and coaching on evidence-based mediations and safety practices resulted in reductions in ventilator-associated events, infection-related ventilator-associated complications and probable ventilator-associated pneumonia and improvements in compliance, according to research published in Critical Care Medicine.

The risk for myocardial infarction is 17 times higher in the 7 days following a respiratory infection, according to research recently published in Internal Medicine Journal.

Approximately one in four adult outpatients prescribed antibiotic therapy for community-acquired pneumonia did not adequately respond to treatment, according to data presented at the 2017 American Thoracic Society International Conference.

The use of broad-spectrum detection methods identified pathogens in more than one-third of children hospitalized with community-acquired pneumonia without a previously identified cause.

The regular use of inhaled corticosteroids is unlikely to increase the risk for pneumonia and other respiratory infections in children with asthma, according to findings from a systematic review published in Pediatrics.

There was an accelerated decline in 30-day risk-standardized readmission rates for myocardial infarction, heart failure and pneumonia after the passage of the Medicare Hospital Readmissions Reduction Program, with the poorest performing hospitals experiencing the greatest reductions, according to new data published in Annals of Internal Medicine.